650 results on '"Giona, Fiorina"'
Search Results
152. Istiocitosi a cellule di Langherans dell’adulto. Manifestazioni orali
153. 99mTc-Sestamibi bone marrow scintigraphy demonstrates the efficacy of long-term enzyme replacement therapy in patients with Gaucher’s disease
154. Treatment‐free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia
155. CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence
156. ITP-QoL Questionnaire for Children with Immune Thrombocytopenia: Italian Version validation's
157. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi
158. Identical, single center policy for unrelated cord blood transplant in young patients with high risk acute lymphoblastic leukemia: a long-term follow up
159. Reverse quantitative polymerase chain reaction (RQ-PCR) for molecular monitoring of Ph plus chronic myelogenous leukemia (CML) children and young adults during imatinib mesylate (STI571) therapy
160. Ph+ chronic myelogenous leukemia (CML): Reverse quantitative polymerase chain reaction (RQ-PCR) for monitoring of patients aged < 20 years in complete cytogenetic response (CCR) following interferon-alpha (IFN)
161. GIMEMA-AIEOP AIDA Protocol for the Treatment of newly diagnosed Acute Promyelocytic Leukemia (APL) in Children
162. 99mTc-sestamibi scintigraphy to monitor the long-term efficacy of enzyme replacement therapy on bone marrow infiltration in patients with Gaucher disease
163. Can Children and Adolescents With Chronic Myelogenous Leukemia Be Cured Without Stem Cell Transplant? A Single Center Experience
164. High Dose Imatinib Is Effective In Children and Adolescents With Chronic Myelogenous Leukemia In Chronic Phase. The Italian Experience
165. Pulmonary Langerhans’ cell histiocytosis (LCH) successfully treated with cyclosporine (CSA)
166. The effect of enzyme repalcement therapy (ERT) in type I Gaucher disease: clinical experience in a adult hematologic Department
167. Correlation of serum chitotriosidase levels with semiquantitative scores of clinical severity and of scintigraphic involvement of the bone m arrow in patients with Gaucher disease
168. The GIMEMA (Gruppo Italiano Malattie Ematologiche dell’Adulto) experience on type I Gaucher disease
169. Durable complete response (CR) to -Interferon (IFN) in recurrent Langerhans’ cell histiocytosis (LCH)
170. Oral involvement in 18 adults with langerhans CELL histiocytosis (lch): diagnostic and therapeutic approaches
171. Trapianto di cellule staminali da sangue di cordone ombelicale in bambini affetti da leucemia acuta ad alto rischio
172. Langerhans Cell Histiocytosis in adults: The retrospective GIMEMA experience and the prospective protocol
173. La leucemia mieloide cronica nel bambino; esperienza in un singolo centro di Ematologia
174. Langerhans’ cell histiocytosis in adults: preliminary results from the GIMEMA retrospective study
175. Unrelated cord blood transplant (CBT) in patients with high risk leukaemia: a long-term follow-up
176. Recidiva extramidollare mastoidea in due pazienti pediatrici con leucemia acuta promielocitica
177. Diagnosi e terapia enzimatica sostitutiva nella malattia di Gaucher
178. La leucemia mieloide cronica nel bambino: esperienza di un singolo centro di ematologia
179. La scintigrafia midollare con 99m Tc-Sestamibi nella identificazione di infiltrazione midollare in pazienti con malattia di Gaucher
180. Juvenile chronic myeloid leukemia (CML): A single center 20-year experience
181. GIMEMA LCH 2001 STUDY: a prospective diagnostic and therapeutic protocol for adults with Langerhans’ Cell Histiocytosis
182. Unifocal Langerhans’ cell histiocytosis involving the central nervous system successfully treated with 2-Chlorodeoxyadenosine
183. Leucemia acuta promielocitica del bambino: risultati del protocollo nazionale AIDA (LAP 0493)
184. Macrophage-derived chemikine in Langerhans cell histiocytosis
185. Assessment of the efficacy of enzyme replacement therapy by Bone Marrow Scintigraphy with 99m Tc-Sestamibi in patients with Gaucher disease
186. Gli anticorpi antifosfolipidi come indice prognostico delle trombocitopenie in età pediatrica
187. Platelet function and coagulation abnormalities in type I Gaucher’s disease patients
188. A single high dose of idarubicin combined with high dose ARA-C for the treatment of first recurrence childhood 'high risk' acute lymphoblastic leukemia (ALL)
189. Bone Marrow Scintigraphy with 99m Tc-Sestamibi in patients with Gaucher disease
190. La splenectomia nei bambini e giovani adulti con porpora trombocitopenica idiopatica (PTI): risultati della splenectomia e analisi dei fattori prognostici influenzanti la risposta all’intervento
191. Fludarabina ed alte dosi di ara-c nelle leucemie acute refrattarie ed in recidiva del bambino
192. Acute promyelocytic leukemia (APL) in children: results of the AIDA Italian protocol
193. Porpora Trombocitopenica Idiopatica (PTI) in età pediatrica: risultati preliminari di un protocollo terapeutico randomizzato utilizzato in un singolo centro
194. Congenital dyserythropoietic anemia type II: a clinical experience of a single centre
195. Gaucher’s disease: the GIMEMA (Gruppo Italiano Malattie Ematologiche dell’Adulto) cooperative group experience
196. Plasma chitotriosidase activity in patients with hereditary spherocytosis
197. Identificati on of a novel complex allele in three unrelated italian patients with Gaucher disease
198. Langerhans cell histiocytosis: the GIMEMA (Gruppo Italiano Malattie Ematologiche dell’Adulto) cooperative group prospects
199. Type I Gaucher's disease: clinical experience at an Italian haematology institution
200. Gaucher's disease: the GIMEMA (Gruppo Italiano Malattie Ematologiche dell’Adulto) experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.